You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(9.30)︱交通銀行:財政部劃轉19.70億股予社保基金;上海醫藥:採納股票期權激勵計劃 激勵對象共211人
格隆匯 09-30 23:16

【業績預告】

保華集團(00498.HK)預計中期業績由盈轉虧

新興光學(00125.HK)預期年度純利大幅低於同期

駿溢環球金融(08350.HK)預期九個月錄得淨虧損

海藍控股(02278.HK)預期年度業績盈轉虧

【財務數據】

AEON 信貸財務(00900.HK)中期純利下降17.66%至1.9億港元

大禹金融(01073.HK)年度淨虧增長184%至1391.6萬港元

亨泰(00197.HK)年度淨虧增長85%至2.85億港元

HKE HOLDINGS(01726.HK)年度純利升157.68%至226.26萬新加坡元

鬆景科技(01079.HK)年度淨虧擴大3.7倍至3873.3萬美元

匯銀控股集團(01178.HK)年度淨虧收窄78.55%至3583.5港元

森美控股(00756.HK)年度業績盈轉虧至23.84億元

伯明翰體育(02309.HK)年度淨虧收窄15.08%至3.61億港元

實力建業(00519.HK)年度業績盈轉虧至7775.1萬港元

麒麟集團控股(08109.HK)年度淨虧收窄40.68%至4641.6萬港元

恆和集團(00513.HK)年度純利跌87.69%至4367.9萬港元 末期息每股0.25港仙

【併購出售】

大悦城地產(00207.HK)附屬斥資31.44億元成功競得濟南地塊

希瑪眼科(03309.HK)完成收購上海璐視德醫療全部股權

中國生物科技服務(08037.HK)終止出售增利控股全部權益

華君國際集團(00377.HK)完成發行收購大連液力機械代價股份

雲南水務(06839.HK)擬4030萬元收購聊城市創聯環保100%股權

運興泰集團(08362.HK)完成出售香港新界兩處物業

福晟國際(00627.HK):福州康安從四川信託受讓湖南德瑞達49%股權

雙樺控股(01241.HK)附屬出售汽車潤滑油公司99.999%股權

文化傳信(00343.HK)擬45萬元購買北京乾智傳視科技餘下45%股權

【重大事項】

上海實業環境(00807.HK)斥資6.6億元與寶武鋼鐵成立合營發展垃圾焚燒發電業務

中國人保(01339.HK):財政部無償劃轉29.9億股A股予社保基金過户完成

中國機械工程(01829.HK)簽署哈薩克斯坦年產300萬噸煤礦及選煤廠建設項目合同

東陽光藥(01558.HK)降尿酸藥物苯溴馬隆片通過一致性評價

白雲山(00874.HK)全資子公司中一藥業收到藥品再註冊批件

中國鐵建(01186.HK)聯合體中標蘭州西固區棚户區改造項目

中國能源建設(03996.HK)附屬簽訂老撾阿速坡省300兆瓦光伏項目EPC合同 合同金額4.5億美元

交通銀行(03328.HK):財政部劃轉19.70億股予社保基金

復星醫藥(02196.HK)子公司擬3.9億港元受讓復鋭醫療科技21.93%股權持股升至74.76%

品創控股(08066.HK)與浙江優盛聯合制作電視劇《雪豹二》

洛陽玻璃(01108.HK)近兩個月累計收到政府補助1873萬元

上海醫藥(02607.HK)採納股票期權激勵計劃 激勵對象共211人

綠領控股(00061.HK)擬攜手四川長征藥業股份開拓醫療大健康領域

基石藥業(02616.HK)CS1001Ib安全性及耐受性良好 CS1001聯合CF化療方案治療食管鱗癌客觀緩解率達77.8%

【回購註銷】

復星國際(00656.HK)9月30日耗資583.21萬港元回購60萬股

小米集團-W(01810.HK)9月30日耗資2億港元回購2275萬股

【增發供股】

瑞港集團(00357.HK)擬配售2億股認購股份 籌資9.38億港元

百濟神州(06160.HK)因購股權獲行使發行3653股

【債務融資】

海通證券(06837.HK)獲中證監核准發行不超過130億元公司債券

越秀地產(00123.HK):廣州市城市建設完成發行15億元債券

【股權激勵】

藥明康德(02359.HK)擬向234名激勵對象授予290.12萬份股票增值權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account